首页/数据集/Cox regression multivariate analysis for oncologic outcome after primary WG-HIFU.

Cox regression multivariate analysis for oncologic outcome after primary WG-HIFU.

Figshare2020-07-23 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Cox_regression_multivariate_analysis_for_oncologic_outcome_after_primary_WG-HIFU_/12699681 数据链接链接失效反馈

官方服务：

资源简介：

Cox regression multivariate analysis for oncologic outcome after primary WG-HIFU.

应用场景：

创建时间：

2020-07-23

结直肠癌辅助化疗

抗肿瘤药物疗效评估

Interventions: experimental group:Apatinib combined with oxaliplatin and capecitabine (XELOX) g Primary outcome(s): Disease free survival Study Design: Single arm

NIAID Data Ecosystem80

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

转移性结直肠癌维持与支持治疗

抗肿瘤药物疗效评估

PURPOSE: This randomized phase III trial is studying maintenance therapy with bevacizumab alone after an induction therapy combining bevacizumab+chemotherapy to see how well they work compared to main

NIAID Data Ecosystem40

Tumor number and volume of offspring at sacrifice (22 weeks).

抗肿瘤药物疗效评估

实验肿瘤学

Data expressed as Mean��SEM and differences between treatment groups were determined by one way ANOVA and appropriate post hoc test. Differences with a p*. n = number of mice/group, tumor volume expre

Figshare2015-12-02 更新10

Cox regression analysis of Framingham risk profiling for the composite endpoint of cardiac events.

心血管风险评估

Cox回归分析

*Dichotomous variable (yes or no). HDL, high-density lipoprotein; hs-cTnT, high-sensitivity cardiac troponin T; Q4, fourth quartile.

Figshare2015-12-02 更新50

Median overall survival and progression-free survival hazard ratios (HRs) and 95% Credible Intervals for cabazitaxel, abiraterone and enzalutamide using Bayesian fixed effects modeling.

抗肿瘤药物疗效评估

贝叶斯生存分析

Median overall survival and progression-free survival hazard ratios (HRs) and 95% Credible Intervals for cabazitaxel, abiraterone and enzalutamide using Bayesian fixed effects modeling.

NIAID Data Ecosystem20

Cox regression multivariate analysis for oncologic outcome after primary WG-HIFU.

资源简介：

相关数据集